Skip to main content

Want a detailed portfolio tracker?

Kairos Pharma (KAPA) P/E (2024 - 2026)

Kairos Pharma (KAPA) P/E from Sep 16, 2024 to Jul 21, 2026. The TTM Kairos Pharma (KAPA) P/E is -1.24. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kairos Pharma (KAPA)

YearP/EChange
2026-1.24-48.86%
2025-2.43-66.90%
2024-7.34N/A

Comparison Kairos Pharma (KAPA) P/E with competitors

Kairos Pharma (KAPA) P/E is -1.24.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.35%
ENLVEnlivex Ltd0.07-106.02%
FGENFibroGen Inc0.24-119.32%
CHRSCoherus Biosciences Inc0.85-168.29%
FBIOFortress Biotech Inc0.95-176.38%
ORMPOramed Pharmaceuticals Inc1.50-220.96%
AGENAgenus Inc3.01-342.20%
INVAInnoviva Inc3.15-353.83%
VXRTVaxart Inc3.55-385.67%
CRMDCorMedix Inc3.63-392.00%
CVACCureVac N.V.4.45-457.77%
GLPGGalapagos NV4.86-491.03%
SRPTSarepta Therapeutics Inc4.88-492.89%
ABEOAbeona Therapeutics Inc5.39-533.57%
ABUSArbutus Biopharma Corp5.60-550.32%
ZVRAZevra Therapeutics Inc5.89-573.78%
SPROSpero Therapeutics Inc6.23-601.24%
CGENCompugen Ltd6.31-608.13%
RIGLRigel Pharmaceuticals6.87-653.04%
SLXNSilexion Therapeutics Corp7.30-687.16%
OMEROmeros Corporation9.26-845.11%
AUPHAurinia Pharmaceuticals Inc9.58-871.37%
PLXProtalix BioTherapeutics Inc10.89-976.47%
ACADAcadia Pharmaceuticals Inc11.73-1043.88%
TBPHTheravance Biopharma Inc12.26-1086.82%
ADMAAdma Biologics Inc12.42-1099.37%
HRMYHarmony Biosciences Holdings Inc13.82-1212.21%
SABSSAB Biotherapeutics Inc14.14-1237.64%
NAGENiagen Bioscience Inc14.82-1292.52%
INCYIncyte Corp15.82-1373.35%
REGNRegeneron Pharmaceuticals Inc15.86-1376.10%
PBYIPuma Biotechnology Inc17.32-1493.52%
CPRXCatalyst Pharmaceuticals Inc17.44-1503.46%
EXELExelixis Inc17.54-1511.41%
TGTXTG Therapeutics Inc18.97-1626.33%
MDXGMimedx Group Inc20.55-1754.00%
XOMAXOMA Royalty Corp22.87-1940.94%
ARGXArgen X SE24.30-2055.48%
CTMXCytomX Therapeutics Inc24.82-2097.58%
XOMAOXOMA Royalty Corp25.34-2139.73%
HALOHalozyme Therapeutics Inc25.62-2162.17%
XOMAPXOMA Royalty Corp25.67-2165.91%
VRTXVertex Pharmaceuticals Inc27.99-2352.99%
RPRXRoyalty Pharma plc - Class A28.69-2408.75%
SLNOSoleno Therapeutics Inc29.02-2435.13%
ASNDAscendis Pharma A/S30.09-2521.26%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3151.13%
APLSApellis Pharmaceuticals Inc39.02-3240.39%
BMRNBiomarin Pharmaceutical Inc42.21-3497.17%
KRYSKrystal Biotech Inc45.34-3749.20%
ONCBeiGene Ltd69.54-5696.56%
PHARPharming Group N.V.75.03-6138.00%
TECHBio-Techne Corp101.96-8305.53%
VCELVericel Corp109.92-8946.38%
ALNYAlnylam Pharmaceuticals Inc117.96-9593.74%
GMABGenmab140.29-11390.49%
TLXTelix Pharmaceuticals Ltd162.15-13149.93%
CORTCorcept Therapeutics Inc212.86-17230.60%